Combination therapy of zibotentan with cisplatinum and paclitaxel is an effective regimen for epithelial ovarian cancer

Laura Rosanò, Roberta Cianfrocca, Francesca Spinella, Valeriana Di Castro, Pier Giorgio Natali, Anna Bagnato

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Combination therapy of zibotentan with cisplatinum and paclitaxel is an effective regimen for epithelial ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences